Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Jazz Pharmaceutical BUYOUT.
View:
Post by alleyesonme on Sep 23, 2022 10:23pm

Jazz Pharmaceutical BUYOUT.

How much would they pay to protect the 6.7 BILLION$$$ investment........measly little medipharm labs is the only threat to billions of highly profitable revenue through the sale of epidiolex and Sativex....I'm shure it's multiples higher than the present 20million canadian valuation given by the public market of a debt free 20+ mil cash on hand company....just ridiculous....
Comment by QuantumFlesh on Sep 24, 2022 1:24pm
This post has been removed in accordance with Community Policy
Comment by alleyesonme on Sep 24, 2022 5:12pm
It's quite possible medipharm is not on the radar of JAZZ because they are one of many participating the the CBD REC market...a market JAZZ doesn't care to be involved in....I don't think JAZZ monitors all REC CBD companies...this Wednesday they will be startled to learn a small Canadian REC participant is actually a fully FDA globally certified cannabinoid pharmaceutical Corp ...more  
Comment by subaru1 on Sep 25, 2022 3:11pm
Alleysome, can give more detail about what will happen wednesday.  Thanks in advance.
Comment by alleyesonme on Sep 25, 2022 4:05pm
Wednesday LABS may submit a patent challenge to the FDA on Epidiolex...the review may take upto 180 days from filing...if successful, LABS, using the DEL and the now active FDA masterfile can ship it's CBD 100 formulation under a new name as a generic for Epidiolex...this is the only FDA approved cannabinoid based pharmaceutical in the U.S and is Pure CBD oil taken as such with a price of 1700 ...more  
Comment by subaru1 on Sep 25, 2022 4:07pm
Thank you very much Alleysome, very good information.
Comment by alleyesonme on Sep 25, 2022 4:22pm
Insurers often only cover the cheaper generic form of a pharmaceutical unless they've negotiated a cheaper than generic price from the brand name...as soon as the generic form is available much of the prescriptions will automatically transfer to the generic by doing of the insurance corps paying for the pharmaceuticals...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities